The highest SHOX2 methylation levels were found in samples from patient with breast (SHOX2: 363%, SEPT9: 0%), a patient with stomach (SHOX2: 270%, SEPT9: 22%) and a patient with lung cancer (SHOX2: 51%, SEPT9: 16%). This evidence concerns the gene SHOX2 and lung cancer.